Catalyst Wire Dossier Catalyst Wire Dossier

MK0517

· Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK0517, covering 2010-06-08 to 2010-06-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Examine the Safety and Tolerability of MK0517 for the Prevention of Post-Operative Nausea and Vomiting (0517-015) [Phase 3]

See pricing